Our results demonstrated that ARPC1A is highly expressed in PCa tissues and is positively associated with malignant clinicopathologic characteristics, suggesting that this protein may be a potential prognostic factor for the progression of PCa. Here, ARPC1A is linked to posterior cortical atrophy.